PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Global Biosimilar Monoclonal Antibodies Market .pdf



Original filename: Global Biosimilar Monoclonal Antibodies Market.pdf
Author: user

This PDF 1.5 document has been generated by Microsoft® Office Word 2007, and has been sent on pdf-archive.com on 20/12/2017 at 13:36, from IP address 1.23.x.x. The current document download page has been viewed 161 times.
File size: 338 KB (4 pages).
Privacy: public file




Download original PDF file









Document preview


Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022
The report on Biosimilar Monoclonal Antibodies Market by Infinium Global Research analyzes over the period
of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market
dynamics, market size and future trends in Global Biosimilar Monoclonal Antibodies Market. It will help a lot
of decision makers to develop strategies and find new opportunities in the Global Biosimilar Monoclonal
Antibodies Market.
The Biosimilar Monoclonal Antibodies Market is driven by rituximab and infliximab submarkets, the rituximab
submarket is accounted as the highest holding market share submarket and the infliximab submarket will
become the leading submarket by 2018 continuing its dominance until 2022. A monoclonal antibody is a type
of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal
antibody is made so that it binds to only one substance to treat different types of cancer. There are several
types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of
monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody
produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each
monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein
they are targeting, hence different monoclonal antibodies are required to be made to target different types of
cancers.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/72
Segments Covered:
The report segments the global biosimilar monoclonal antibodies market by drug class and by application.The
market segmentation based on drug class includes, rituximab, infliximab, abciximab, trastuzumab,

adalimumab, and bevacizumab. Moreover, based on application the biosimilar monoclonal antibodies market
is segmented into oncology, chronic and auto immune diseases, growth hormone deficiency and infectious
diseases.
Companies Profiled:














Pfizer Inc
Novartis AG
Reliance Life Sciences
Allergan plc
Coherus BioSciences Inc
Biocon
Dr. Reddy’s Laboratories Ltd.
Boehringer Ingelheim GmbH
BioXpress Therapeutics SA
Intas Pharmaceuticals Limited
BIOCAD
Genor BioPharma Co. Ltd
Celltrion Inc

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/72
Key topics covered:
1. Report Overview
2. Executive Summary

3. Global Biosimilar Monoclonal Antibodies Market Overview
4. Global Biosimilar Monoclonal Antibodies Market, by Drug Class, (USD Million) 2015 – 2022
5. Global Biosimilar Monoclonal Antibodies Market, by Application, (USD Million) 2015 – 2022
6. Global Biosimilar Monoclonal Antibodies Market, by Region, (USD Million) 2015 – 2022
7 Company Profiles
Click to View Complete Report @
https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_biosimilar_monoclonal_anti
bodies_market


Global Biosimilar Monoclonal Antibodies Market.pdf - page 1/4
Global Biosimilar Monoclonal Antibodies Market.pdf - page 2/4
Global Biosimilar Monoclonal Antibodies Market.pdf - page 3/4
Global Biosimilar Monoclonal Antibodies Market.pdf - page 4/4

Related documents


global biosimilar monoclonal antibodies market
biological drugs market
aarkstore prepacked column market by type
cancer immunotherapy market
biosimilar market
oncology biosimilars market


Related keywords